Get started
Amgen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.03571 ShAmgen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.03571 ShAmgen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.03571 Sh

Amgen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.03571 Sh

No trades
OverviewFinancialsNewsIdeasMindsTechnicalsSeasonalsBonds

Chart


Full chart

Key stats


Market capitalization
‪955.97 B‬ BRL
Dividend yield (indicated)
2.11%
Price to earnings Ratio (TTM)
24,257.69
Basic EPS (TTM)
0.00 BRL
Net income (FY)
‪22.05 B‬ BRL
Revenue (FY)
‪179.15 B‬ BRL
Shares float
—
Beta (1Y)
0.17

About Amgen Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Robert A. Bradway
Website
amgen.com
Headquarters
Thousand Oaks
Founded
1980
Identifiers
2
ISIN BRAMGNBDR004
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Check out other big names from the same industry as AMGN34.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


US31162DU1
Amgen Inc. 5.75% 02-MAR-2063
Yield to maturity
5.87%
Maturity date
Mar 2, 2063
AMGN3854930
Amgen Inc. 5.375% 15-MAY-2043
Yield to maturity
5.85%
Maturity date
May 15, 2043
AMGN.GA
Amgen Inc. 8.125% 01-APR-2097
Yield to maturity
5.84%
Maturity date
Apr 1, 2097
US31162DG2
Amgen Inc. 4.4% 22-FEB-2062
Yield to maturity
5.84%
Maturity date
Feb 22, 2062
US31162DT4
Amgen Inc. 5.65% 02-MAR-2053
Yield to maturity
5.75%
Maturity date
Mar 2, 2053
US31162DK3
Amgen Inc. 4.875% 01-MAR-2053
Yield to maturity
5.72%
Maturity date
Mar 1, 2053
AMGD
Amgen Inc. 4.2% 22-FEB-2052
Yield to maturity
5.69%
Maturity date
Feb 22, 2052
US031162CF59
Amgen Inc. 4.663% 15-JUN-2051
Yield to maturity
5.69%
Maturity date
Jun 15, 2051
AMGN4437315
Amgen Inc. 4.563% 15-JUN-2048
Yield to maturity
5.66%
Maturity date
Jun 15, 2048
AMGN5186584
Amgen Inc. 2.77% 01-SEP-2053
Yield to maturity
5.63%
Maturity date
Sep 1, 2053
US31162BZ2
Amgen Inc. 4.4% 01-MAY-2045
Yield to maturity
5.62%
Maturity date
May 1, 2045

See all AMGN34 bonds